• 1
    Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 160S98S.
  • 2
    Olson JD, Brandt JT, Chandler WL, van Cott EM, Cunningham MT, Hayes TE, Kottke-Marchant KK, Makar RS, Uy AB, Wang EC. Laboratory reporting of the international normalized ratio: progress and problems. Arch Pathol Lab Med 2007; 131: 16417.
  • 3
    van den Besselaar AM. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis 2001; 12: 3540.
  • 4
    Tripodi A, Chantarangkul V, Mannucci P. Near-patient testing devices to monitor oral anticoagulant therapy. Br J Haematol 2001; 113: 84752.
  • 5
    Poller L. International Normalized Ratios (INR): the first 20 years. J Thromb Haemost 2004; 2: 84960.
  • 6
    World Health Organization. WHO Expert Committee on Biological Standardization Guidelines for Thromboplastins and Plasma Used to Control Oral Anticoagulant Therapy. WHO Technical Report Series no. 889. Geneva: WHO, 1999: 6493.
  • 7
    Ansell JE, Hughes R. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J 1996; 132: 1095100.
  • 8
    Errichetti AM, Holden A, Ansell J. Management of oral anticoagulant therapy. Experience with an anticoagulation clinic. Arch Intern Med 1984; 144: 19668.
  • 9
    Roudaut R. Self-control of long-term oral anticoagulation using a point-of-care device. Arch Cardiovasc Dis 2008; 101: 6834.
  • 10
    Garcia-Alamino JM, Ward AM, Alonso-Coello P, Perera R, Bankhead C, Fitzmaurice D, Heneghan CJ. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev 2010; 4: CD003839.
  • 11
    Poller L, Shiach CR, MacCallum PK, Johansen AM, Münster AM, Magalhaes A, Jespersen J. Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation. Lancet 1998; 352: 15059.
  • 12
    Thompson JL, Sundt TM, Sarano ME, Santrach PJ, Schaff HV. In-patient international normalized ratio self-testing instruction after mechanical heart valve implantation. Ann Thorac Surg 2008; 85: 204650.
  • 13
    Holm T, Lassen JF, Husted SE, Christensen P, Heickendorff L. A randomized controlled trial of shared care versus routine care for patients receiving oral anticoagulant therapy. J Intern Med 2002; 252: 32231.
  • 14
    Jespersen J, Poller L, van den Besselaar AM, van der Meer FJ, Palareti G, Tripodi A, Shiach C, Keown M, Ibrahim S. External quality assessment (EQA) for CoaguChek monitors. Thromb Haemost 2010; 103: 93641.
  • 15
    Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 13560.
  • 16
    Bruns DE, Huth EJ, Magid E, Young DS. Toward a checklist for reporting of studies of diagnostic accuracy of medical tests. Clin Chem 2000; 46: 8935.
  • 17
    van den Besselar AM. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. Thromb Haemost 2000; 84: 41012.
  • 18
    Kjeldsen J, Lassen JF, Petersen PH, Brandslund I. Biological variation of International Normalized Ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: computer simulation of serial measurements with goal-setting for analytical quality. Clin Chem 1997; 43: 217582.
  • 19
    Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993; 153: 14417.
  • 20
    Douketis JD, Lane A, Milne J, Ginsberg JS. Accuracy of a portable International Normalization Ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998; 92: 1117.
  • 21
    Poller L, Keown M, Ibrahim SA, van der Meer FJ, van den Besselaar AM, Tripodi A, Jespersen J, Meijer P, Kluft C. Quality assessment of CoaguChek point-of-care prothrombin time monitors: comparison of the European community-approved procedure and conventional external quality assessment. Clin Chem 2006; 52: 18437.
  • 22
    Lassen JF, Brandslund I, Antonsen S. International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements. Clin Chem 1995; 41: 4447.
  • 23
    Lassen JF, Kjeldsen J, Antonsen S, Hyltoft PP, Brandslund I. Interpretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy. Clin Chem 1995; 41: 11716.
  • 24
    Phillips EM, Buchan DA, Newman N, Rajan A, Zia S. Low-molecular-weight heparin may alter point-of-care assay for international normalized ratio. Pharmacotherapy 2005; 25: 13417.
  • 25
    van Cott EM. Point-of-care testing in coagulation. Clin Lab Med 2009; 29: 54353.
  • 26
    van den Besselaar AM, Witteveen E, van der Meer FJ. Influence of haematocrit on international normalised ratio (INR) differences between a whole blood point-of-care coagulation monitor and reference prothrombin time in plasma. Thromb Haemost 2008; 100: 11814.
  • 27
    Perry SL, Samsa GP, Ortel TL. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies. Thromb Haemost 2005; 94: 1196202.
  • 28
    Ansell J, Jacobson A, Levy J, Völler H, Hasenkam JM. Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation. Int J Cardiol 2005; 99: 3745.
  • 29
    Braun S, Spannagl M, Völler H. Patient self-testing and self-management of oral anticoagulation. Anal Bioanal Chem 2009; 393: 146371.
  • 30
    Spinler SA, Nutescu EA, Smythe MA, Wittkowsky AK. Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors. Ann Pharmacother 2005; 39: 104955.
  • 31
    Gosselin R, Owings JT, White RH, Hutchinson R, Branch J, Mahackian K, Johnston M, Larkin EC. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thromb Haemost 2000; 83: 698703.
  • 32
    Loebstein R, Kurnik D, Lubetsky A, Ezra D, Halkin H. Potential dosing errors using portable prothrombin time monitoring devices. Blood Coagul Fibrinolysis 2003; 14: 47983.
  • 33
    Ansell JE, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM, Fish L. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995; 155: 21859.
  • 34
    Le DT, Weibert RT, Sevilla BK, Donnelly KJ, Rapaport SI. The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods. Ann Intern Med 1994; 120: 5528.
  • 35
    Ansell J, Holden A, Knapic N. Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times. Arch Intern Med 1989; 149: 250911.
  • 36
    White RH, McCurdy SA, von Marensdorff H, Woodruff DE Jr, Leftgoff L. Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Ann Intern Med 1989; 111: 7307.
  • 37
    Kaatz SS, White RH, Hill J, Mascha E, Humphries JE, Becker DM. Accuracy of laboratory and portable monitor international normalized ratio determinations. Comparison with a criterion standard. Arch Intern Med 1995; 155: 18617.
  • 38
    White RH, Becker DM, Gunther-Maher MG. Outpatient use of a portable international normalized ratio/prothrombin time monitor. South Med J 1994; 87: 20610.
  • 39
    Jennings I, Luddington RJ, Baglin T. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation. J Clin Pathol 1991; 44: 9503.
  • 40
    Rigelsky JM, Choe HM, Curtis DM, Brosnan MJ, Mitrovich S, Streetman DS. Accuracy of the avosure PT pro system compared with a hospital laboratory standard. Ann Pharmacother 2002; 36: 3805.
  • 41
    Andrew M, Ansell JK, Becker DM, Becker RC, Triplett DA. Oral Anticoagulation Monitoring Study Group. Prothrombin measurement using a patient self-testing system. Am J Clin Pathol 2001; 115: 2807.
  • 42
    Oral Anticoagulation Monitoring Study Group. Point-of-care prothrombin time measurement for professional and patient self-testing use. A multicenter clinical experience. Am J Clin Pathol 2001; 115: 28896.
  • 43
    Kitchen S, Preston FE. Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins. J Clin Pathol 1997; 50: 9516.
  • 44
    Cachia PG, McGregor E, Adlakha S, Davey P, Goudie BM. Accuracy and precision of the TAS analyser for near-patient INR testing by non-pathology staff in the community. J Clin Pathol 1998; 51: 6872.
  • 45
    Karon BS, McBane RD, Chaudhry R, Beyer LK, Santrach PJ. Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers. Am J Clin Pathol 2008; 130: 8892.
  • 46
    Plesch W, Wolf T, Breitenbeck N, Dikkeschei LD, Cervero A, Perez PL, van den Besselaar AM. Results of the performance verification of the CoaguChek XS system. Thromb Res 2008; 123: 3819.
  • 47
    Kong MC, Lim TG, Ng HJ, Chan YH, Lee LH. Feasibility, cost-effectiveness and patients’ acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic. Ann Hematol 2008; 87: 90510.
  • 48
    Plesch W, van den Besselaar AM. Validation of the international normalized ratio (INR) in a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Int J Lab Hematol 2009; 31: 205.
  • 49
    Nam MH, Roh KH, Pak HN, Lee CK, Kim YH, Lee KN, Cho Y. Evaluation of the Roche CoaguChek XS handheld coagulation analyzer in a cardiac outpatient clinic. Ann Clin Lab Sci 2008; 38: 3740.
  • 50
    Williams VK, Griffiths AB. Acceptability of CoaguChek S and CoaguChek XS generated international normalised ratios against a laboratory standard in a paediatric setting. Pathology 2007; 39: 5759.
  • 51
    Braun S, Watzke H, Hasenkam JM, Schwab M, Wolf T, Dovifat C, Völler H. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR self-management. Thromb Haemost 2007; 97: 31014.
  • 52
    Sobieraj-Teague M, Daniel D, Farrelly B, Coghlan D, Gallus A. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting. Thromb Res 2009; 123: 90913.
  • 53
    Torreiro EG, Fernandez EG, Rodriguez RM, Lopez CV, Nunez JB. Comparative study of accuracy and clinical agreement of the CoaguChek XS portable device versus standard laboratory practice in unexperienced patients. Thromb Haemost 2009; 101: 96974.
  • 54
    Christensen TD, Larsen TB, Jensen C, Maegaard M, Sørensen B. International normalised ratio (INR) measured on the CoaguChek S and XS compared with the laboratory for determination of precision and accuracy. Thromb Haemost 2009; 101: 5639.
  • 55
    Paioni P, Kroiss S, Kagi E, Bergstrasser E, Fasnacht M, Bauersfeld U, Schmugge M, Albisetti M. Self-monitoring of oral anticoagulation therapy in children. Acta Haematol 2009; 122: 5863.
  • 56
    Bauman ME, Black KL, Massicotte MP, Bauman ML, Kuhle S, Howlett-Clyne S, Cembrowski GS, Bajzar L. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin. Thromb Haemost 2008; 99: 1097103.
  • 57
    Greenway A, Ignjatovic V, Summerhayes R, Newall F, Burgess J, DeRosa L, Monagle P. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95). Thromb Haemost 2009; 102: 15965.
  • 58
    Bereznicki LR, Jackson SL, Peterson GM, Jeffrey EC, Marsden KA, Jupe DM. Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring. J Clin Pathol 2007; 60: 31114.
  • 59
    Biasiolo A, Rampazzo P, Furnari O, Filippi B, Pengo V. Comparison between routine laboratory prothrombin time measurements and fingerstick determinations using a near-patient testing device (Pro-Time)30. Thromb Res 2000; 97: 4958.
  • 60
    Gardiner C, Longair I, Hills J, Cohen H, Mackie IJ, Machin SJ. Performance evaluation of a new small-volume coagulation monitor: the SmartCheck INR system. Am J Clin Pathol 2008; 129: 5004.
  • 61
    McBane RD, Felty CL, Hartgers ML, Chaudhry R, Beyer LK, Santrach PJ. Importance of device evaluation for point-of-care prothrombin time international normalized ratio testing programs. Mayo Clin Proc 2005; 80: 1816.
  • 62
    Murray ET, Fitzmaurice DA, Allan TF, Hobbs FD. A primary care evaluation of three near patient coagulometers. J Clin Pathol 1999; 52: 8425.
  • 63
    Taborski U, Braun SL, Völler H. Analytical performance of the new coagulation monitoring system INRatio for the determination of INR compared with the coagulation monitor Coaguchek S and an established laboratory method. J Thromb Thrombolysis 2004; 18: 1037.
  • 64
    Hemkens LG, Hilden KM, Hartschen S, Kaiser T, Didjurgeit U, Hansen R, Bender R, Sawicki PT. A randomized trial comparing INR monitoring devices in patients with anticoagulation self-management: evaluation of a novel error-grid approach. J Thromb Thrombolysis 2008; 26: 2230.
  • 65
    Nowatzke WL, Landt M, Smith C, Wilhite T, Canter C, Luchtman-Jones L. Whole blood international normalization ratio measurements in children using near-patient monitors. J Pediatr Hematol Oncol 2003; 25: 337.
  • 66
    van den Besselaar AM, Barrowcliffe TW, Houbouyan-Reveillard LL, Jespersen J, Johnston M, Poller L, Tripodi A. Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost 2004; 2: 194653.
  • 67
    Fitzmaurice DA, Machin SJ. Recommendations for patients undertaking self management of oral anticoagulation. BMJ 2001; 323: 9859.
  • 68
    Christensen TD, Attermann J, Hjortdal VE, Maegaard M, Hasenkam JM. Self-management of oral anticoagulation in children with congenital heart disease. Cardiol Young 2001; 11: 26976.
  • 69
    Christensen TD, Attermann J, Pilegaard HK, Andersen NT, Maegaard M, Hasenkam JM. Self-management of oral anticoagulant therapy for mechanical heart valve patients. Scand Cardiovasc J 2001; 35: 10713.
  • 70
    Murray ET, Fitzmaurice DA, McCahon D. Point of care testing for INR monitoring: where are we now? Br J Haematol 2004; 127: 3738.
  • 71
    Christensen TD. Self-management of oral anticoagulant therapy: a review. J Thromb Thrombolysis 2004; 18: 12743.
  • 72
    Bhavnani M, Shiach CR. Patient self-management of oral anticoagulation. Clin Lab Haematol 2002; 24: 2537.
  • 73
    Murray ET, Kitchen DP, Kitchen S, Jennings I, Woods TA, Preston FE, Fitzmaurice DA. Patient self-management of oral anticoagulation and external quality assessment procedures. Br J Haematol 2003; 122: 8258.
  • 74
    Solvik UO, Stavelin A, Christensen NG, Sandberg S. External quality assessment of prothrombin time: the split-sample model compared with external quality assessment with commercial control material. Scand J Clin Lab Invest 2006; 66: 33749.
  • 75
    Murray ET, Jennings I, Kitchen D, Kitchen S, Fitzmaurice DA. Quality assurance for oral anticoagulation self management: a cluster randomized trial. J Thromb Haemost 2008; 6: 4649.
  • 76
    Meijer P, Kluft C, Poller L, van der Meer FJ, Keown M, Ibrahim S, van den Besselaar AM, Tripodi A, Jespersen J. A national field study of quality assessment of CoaguChek point-of-care testing prothrombin time monitors. Am J Clin Pathol 2006; 126: 75661.
  • 77
    Poller L, Keown M, Chauhan N, van den Besselaar AM, Tripodi A, Jespersen J, Shiach C, Horellou MH, Dias D, Egberg N, Iriarte JA, Kontopoulou-Griva I, Otridge B. European Concerted Action on Anticoagulation (ECAA): multicentre international sensitivity index calibration of two types of point-of-care prothrombin time monitor systems. Br J Haematol 2002; 116: 84450.
  • 78
    Poller L, Keown M, Chauhan N, van den Besselaar AM, Meeuwisse-Braun J, Tripodi A, Clerici M, Jespersen J. European concerted action on anticoagulation. Use of plasma samples to derive international sensitivity index for whole-blood prothrombin time monitors. Clin Chem 2002; 48: 25560.
  • 79
    Poller L, Keown M, Chauhan N, van den Besselaar AM, Tripodi A, Shiach C, Jespersen J. European concerted action on anticoagulation – comparison of fresh plasma and whole blood multicentre ISI calibrations of CoaguChek Mini and TAS PT-NC whole blood prothrombin time point-of-care monitors. Thromb Haemost 2002; 87: 85966.
  • 80
    Poller L, Keown M, Chauhan N, van den Besselaar AM, Tripodi A, Jespersen J, Shiach C. European concerted action on anticoagulation. Minimum numbers of lyophilized plasma samples for ISI calibration of CoaguChek and TAS point-of-care whole blood prothrombin time monitors. Am J Clin Pathol 2003; 119: 23240.
  • 81
    Near Patient Testing Working Party, General Haematology Task Force of BCSH, Thrombosis and Haemostasis Task Force of BCSH. Guide-lines for near patient testing: haematology. Clin Lab Haematol 1995; 17: 30110.
  • 82
    Havrda DE, Hawk TL, Marvin CM. Accuracy and precision of the CoaguChek S versus laboratory INRs in a clinic. Ann Pharmacother 2002; 36: 76975.
  • 83
    Poller L, Keown M, Chauhan N, van den Besselaar AM, Tripodi A, Shiach C, Jespersen J. Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods. BMJ 2003; 327: 302.
  • 84
    Kitchen S, Kitchen DP, Jennings I, Woods TA, Walker ID, Preston FE. Point-of-care International Normalised Ratios: UK NEQAS experience demonstrates necessity for proficiency testing of three different monitors. Thromb Haemost 2006; 96: 5906.
  • 85
    Ng VL. Anticoagulation monitoring. Clin Lab Med 2009; 29: 283304.
  • 86
    Poller L. Precision and accuracy of CoaguChek S and XS monitors: the need for external quality assessment. Thromb Haemost 2009; 101: 41921.
  • 87
    Favaloro EJ, Adcock DM. Standardization of the INR: how good is your laboratory’s INR and can it be improved? Semin Thromb Hemost 2008; 34: 593603.
  • 88
    Adcock DM, Johnston M. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study. Thromb Haemost 2002; 87: 749.
  • 89
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 30710.
  • 90
    Hasenkam JM, Kimose HH, Knudsen L, Grønnesby H, Halborg J, Christensen TD, Attermann J, Pilegaard HK. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardiothorac Surg 1997; 11: 93542.
  • 91
    Sidhu P, O’Kane HO. Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients. Ann Thorac Surg 2001; 72: 15237.
  • 92
    Kitchen D, Murray E, Kitchen S, Jennings I, Fitzmaurice D, Woods T, Walker I. External quality assessment for prothrombin time/international normalised ratio using point-of-care devices: split-sample or conventional external quality assessment using control samples? Scand J Clin Lab Invest 2007; 67: 6735.
  • 93
    Barcellona D, Fenu L, Cornacchini S, Marongiu F. Point-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful? Thromb Res 2009; 123: 7759.
  • 94
    Kitchen S, Kitchen D, Jennings I, Woods T, Walker I. Quality assessment of CoaguChek point-of-care international normalized ratio monitors: a note of caution. Clin Chem 2007; 53: 15556.
  • 95
    Spannagl M, Dick A, Reinauer H. External quality assessment schemes in coagulation in Germany: between regulatory bodies and patient outcome. Semin Thromb Hemost 2007; 33: 25964.
  • 96
    Poller L, Keown M, Chauhan N, van den Besselaar AM, Tripodi A, Jespersen J, Shiach C. Minimum numbers of fresh whole blood and plasma samples from patients and healthy subjects for ISI calibration of CoaguChek and RapidPointCoag monitors. Am J Clin Pathol 2002; 117: 8929.
  • 97
    Leichsenring I, Plesch W, Unkrig V, Kitchen S, Kitchen DP, Maclean R, Dikkeschei B, van den Besselaar AM. Multicentre ISI assignment and calibration of the INR measuring range of a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Thromb Haemost 2007; 97: 85661.
  • 98
    Attermann J. Monitoring Oral Anticoagulant Therapy; Measuring Coagulant Activity. Ph.D. Thesis. Aarhus: Faculty of Health Sciences, Aarhus University, 2000.